Clinical data | |
---|---|
Trade names | Omegaven |
Other names | Fish oil triglycerides |
AHFS/ Drugs.com | Professional Drug Facts |
License data | |
Pregnancy category |
|
Dependence liability | Intravenous |
Drug class | Intravenous nutritional products |
ATC code |
|
Legal status | |
Legal status |
Fish oil, sold under the brand name Omegaven, is a fatty acid emulsion. [2] It is used for total parenteral nutrition (feeding directly into a venous catheter), e.g. in short bowel syndrome. [2] It is rich in omega-3 fatty acids. [2]
Fish oil triglycerides was approved for use in the United States in July 2018, [3] and is available to people on the US market by prescription effective November 2018. [4]
In 2021, it was the 283rd most commonly prescribed medication in the United States, with more than 700,000 prescriptions. [5] [6]
It has gained popularity in children in preference to the more commonly used intralipid after case reports that it reduced the risk of liver damage. [7]
A 2007, study indicated that the use of Omegaven may be an appropriate intervention strategy for newborns with a very low birth weight, gastroschisis, and intestinal atresia. [8]
A clinical trial exploring the use of fish oil as an adjunct to parenteral nutrition in surgical intensive care units at National Taiwan University Hospital completed in March 2007. [9]
Although the use of fish oil triglycerides in children in the United States is experimental, the use of it in adults in Europe is less controversial. [10] In European studies, fish oil triglycerides have been associated with a reduction in psoriasis, when contrasted to administration of omega-6 fatty acid Lipoven. [11] Fish oil triglycerides have also been associated with reduced mortality and antibiotic use during hospital stays. [12]
Clinical data | |
---|---|
Trade names | Omegaven |
Other names | Fish oil triglycerides |
AHFS/ Drugs.com | Professional Drug Facts |
License data | |
Pregnancy category |
|
Dependence liability | Intravenous |
Drug class | Intravenous nutritional products |
ATC code |
|
Legal status | |
Legal status |
Fish oil, sold under the brand name Omegaven, is a fatty acid emulsion. [2] It is used for total parenteral nutrition (feeding directly into a venous catheter), e.g. in short bowel syndrome. [2] It is rich in omega-3 fatty acids. [2]
Fish oil triglycerides was approved for use in the United States in July 2018, [3] and is available to people on the US market by prescription effective November 2018. [4]
In 2021, it was the 283rd most commonly prescribed medication in the United States, with more than 700,000 prescriptions. [5] [6]
It has gained popularity in children in preference to the more commonly used intralipid after case reports that it reduced the risk of liver damage. [7]
A 2007, study indicated that the use of Omegaven may be an appropriate intervention strategy for newborns with a very low birth weight, gastroschisis, and intestinal atresia. [8]
A clinical trial exploring the use of fish oil as an adjunct to parenteral nutrition in surgical intensive care units at National Taiwan University Hospital completed in March 2007. [9]
Although the use of fish oil triglycerides in children in the United States is experimental, the use of it in adults in Europe is less controversial. [10] In European studies, fish oil triglycerides have been associated with a reduction in psoriasis, when contrasted to administration of omega-6 fatty acid Lipoven. [11] Fish oil triglycerides have also been associated with reduced mortality and antibiotic use during hospital stays. [12]